Effect of deoxynojirimycin derivatives on morphogenesis of hepatitis C virus

[1]  A. V. Timokhova,et al.  Effect of deoxynojirimycin derivatives on morphogenesis of hepatitis C virus , 2012, Molecular Biology.

[2]  P. Kwo.  Screening for hepatitis C virus infection. , 2012, Gastroenterology & hepatology.

[3]  J. McLauchlan,et al.  Hepatitis C Virus: Assembly and Release of Virus Particles* , 2010, The Journal of Biological Chemistry.

[4]  N. N. Koroleva,et al.  Hepatitis C virus structural proteins and virus-like particles produced in recombinant baculovirus-infected insect cells , 2010, Molecular Biology.

[5]  Haomiao Ouyang,et al.  Class IIC alpha-mannosidase AfAms1 is required for morphogenesis and cellular function in Aspergillus fumigatus. , 2009, Glycobiology.

[6]  C. Staib,et al.  Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model , 2008, The journal of gene medicine.

[7]  T. Wakita,et al.  Molecular biology of hepatitis C virus , 2007, Journal of Gastroenterology.

[8]  F. Penin,et al.  The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein , 2007, Journal of Virology.

[9]  R. Dwek,et al.  Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors. , 2007, The Journal of general virology.

[10]  D. Mutimer,et al.  Disappointing results of combination therapy for HCV? , 2006, Gut.

[11]  R. Dwek,et al.  Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles. , 2006, The Journal of general virology.

[12]  R. Chou,et al.  Screening for Hepatitis C Virus Infection: A Review of the Evidence for the U.S. Preventive Services Task Force , 2004, Annals of Internal Medicine.

[13]  R. Dwek,et al.  Effects of Interferon, Ribavirin, and Iminosugar Derivatives on Cells Persistently Infected with Noncytopathic Bovine Viral Diarrhea Virus , 2004, Antimicrobial Agents and Chemotherapy.

[14]  E. Trombetta,et al.  The contribution of N-glycans and their processing in the endoplasmic reticulum to glycoprotein biosynthesis. , 2003, Glycobiology.

[15]  Y. Jeong,et al.  Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Virus Infection , 2003 .

[16]  J. Stapleton,et al.  Recombinant hepatitis C virus‐like particles expressed by baculovirus: Utility in cell‐binding and antibody detection assays , 2002, Journal of medical virology.

[17]  Dieter Häussinger,et al.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.

[18]  P. Farci,et al.  Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [Science 1989;244:359-362]. , 2002, Journal of hepatology.

[19]  A. G. Shatalov,et al.  [Genome analysis of hepatitis C virus strain 274933RU isolated in Russian Federation]. , 2002, Voprosy virusologii.

[20]  R. Dwek,et al.  Study of the Mechanism of Antiviral Action of Iminosugar Derivatives against Bovine Viral Diarrhea Virus , 2001, Journal of Virology.

[21]  R. Dwek,et al.  Antiviral Effect ofN-Butyldeoxynojirimycin against Bovine Viral Diarrhea Virus Correlates with Misfolding of E2 Envelope Proteins and Impairment of Their Association into E1-E2 Heterodimers , 2001, Journal of Virology.

[22]  P. Desprès,et al.  α-Glucosidase Inhibitors Reduce Dengue Virus Production by Affecting the Initial Steps of Virion Morphogenesis in the Endoplasmic Reticulum , 2000, Journal of Virology.

[23]  C. Rice,et al.  Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. , 2000, Current topics in microbiology and immunology.

[24]  H. Petry,et al.  Molecular Cloning and Expression of Major Structural Protein VP1 of the Human Polyomavirus JC Virus: Formation of Virus-Like Particles Useful for Immunological and Therapeutic Studies , 1999, Journal of Virology.

[25]  R. Consigli,et al.  Use of the baculovirus system to assemble polyomavirus capsid-like particles with different polyomavirus structural proteins: analysis of the recombinant assembled capsid-like particles. , 1999, The Journal of general virology.

[26]  M. Aebi,et al.  The dolichol pathway of N-linked glycosylation. , 1999, Biochimica et biophysica acta.

[27]  D. Wong,et al.  Hepatitis C Virus Structural Proteins Assemble into Viruslike Particles in Insect Cells , 1998, Journal of Virology.

[28]  C. Rice,et al.  Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin , 1996, Journal of virology.

[29]  D. Dunigan,et al.  The Baculovirus Expression System: A Laboratory Guide , 1992 .

[30]  L. King,et al.  The Baculovirus Expression System , 1992 .

[31]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[32]  H. Sambrook.  Molecular cloning : a laboratory manual. Cold Spring Harbor, NY , 1989 .

[33]  G S Jacob,et al.  Aminosugar derivatives as potential anti-human immunodeficiency virus agents. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H Babich,et al.  Comparisons of two in vitro cytotoxicity assays-The neutral red (NR) and tetrazolium MTT tests. , 1988, Toxicology in vitro : an international journal published in association with BIBRA.

[35]  T. Shikata,et al.  [Non-A, non-B viral hepatitis]. , 1985, Nihon rinsho. Japanese journal of clinical medicine.

[36]  E Borenfreund,et al.  Toxicity determined in vitro by morphological alterations and neutral red absorption. , 1985, Toxicology letters.

[37]  S. Kornfeld,et al.  Assembly of asparagine-linked oligosaccharides. , 1985, Annual review of biochemistry.

[38]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[39]  M. Marks,et al.  Measures of viability in isolated cells. , 1975, Biochemical medicine.